The winners of this year’s CPHI Pharma Awards 2025 were announced last night at a prestigious ceremony celebrating outstanding achievements across pharmaceutical innovation, leadership, manufacturing, sustainability and women in pharma.
The awards ceremony took place at CPHI Frankfurt and welcomed pharma professionals from across the globe.
The celebrations recognised groundbreaking advancements, and companies and individuals whose innovations and achievements are helping to shape the future of the industry.
“This year, we received an incredible number of outstanding award submissions, and it was tough to choose winners for each category. "
"Last night was an opportunity to celebrate excellence across our industry, and the winners and those shortlisted for an award should be so proud of their achievements,” said Tara Dougal, Events Director, Pharma Portfolio, Informa Markets.
The winners of each category are as follows:
- API Development & Innovation: Corden Pharma International — TAPS: TAG Assisted Peptide Synthesis
- Accelerating Innovation: NunaBio — Custom, cell-free, synthetic DNA
- At the Heart of Pharma: CNX Therapeutics — Talent without barriers
- CEO of the Year: Lars Petersen, FUJIFILM Biotechnologies
- Drug Delivery and Device Innovation: Ypsomed - YpsoLoop: the prefilled autoinjector
- Finished Formulation: Evonik Industries: EUDRACAP colon
- Future Leader: Yolanda Gomez of Esteve CDMO
- Manufacturing Excellence: Enzene: EnzeneX — Fully-connected continuous manufacturing
- Packaging and Machinery: SCHOTT Pharma: SCHOTT TOPPAC infuse – the next generation
- Start-Up Initiative: Green Elephant Biotech — CellScrew
- Supply Chain Excellence: Cryoport Systems — Cryoport Systems’ Integrated End-to-End Supply Chain Platform
- Sustainability: Botanical Solution: Sustainability Grows on Trees — Producing QS-21, the Gold Standard vaccine adjuvant
- Woman of the Year: Adriana Kiędzierska-Mencfeld, CEO, RezonBio.
Entries for the CPHI Pharma Awards 2026 open in February 2026.